Great West Life Assurance CO Amgen Inc Transaction History

Great West Life Assurance CO

$49.6 Billion
Q1 2024

A detailed history of Great West Life Assurance CO transactions in Amgen Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 49,931 shares of AMGN stock, worth $15.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

49,931

Previous 48,620 2.7%

Holding current value

$15.5 Million

Previous $13.9 Million 2.17%

% of portfolio

0.03%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $352,488 - $425,498	1,311 Added 2.7%	49,931 $14.2 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $1.68 Million - $1.9 Million	-6,585 Reduced 11.93%	48,620 $13.9 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $9.23 Million - $11.5 Million	42,220 Added 325.14%	55,205 $14.8 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $10.5 Million - $12.4 Million	-48,918 Reduced 79.02%	12,985 $2.89 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $12 Million - $14.7 Million	53,263 Added 616.47%	61,903 $14.9 Million

Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $146,350 - $185,955	-639 Reduced 6.89%	8,640 $2.28 Million
Q3 2022 Nov 01, 2022	BUY	$224.46 - $253.15 $2.08 Million - $2.35 Million	9,279 New	9,279 $2.09 Million
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $172 Million - $191 Million	-744,150 Reduced 98.77%	9,264 $2.25 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $4.79 Million - $5.3 Million	21,830 Added 2.98%	753,414 $192 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $144 Million - $165 Million	724,871 Added 10798.02%	731,584 $164 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $7.55 Million - $8.84 Million	-35,557 Reduced 84.12%	6,713 $1.44 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $4.84 Million - $5.37 Million	20,732 Added 96.26%	42,270 $10.3 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $135 Million - $157 Million	-608,963 Reduced 96.58%	21,538 $5.34 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $3.54 Million - $4.21 Million	-16,342 Reduced 2.53%	630,501 $145 Million
Q3 2020 Nov 17, 2020	SELL	$234.65 - $260.95 $16.5 Million - $18.3 Million	-70,244 Reduced 9.8%	646,843 $164 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $18.9 Million - $21 Million	80,574 Added 12.66%	717,087 $182 Million
Q2 2020 Aug 17, 2020	BUY	$197.81 - $242.74 $7.96 Million - $9.77 Million	40,232 Added 6.75%	636,513 $149 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $4.7 Million - $6.24 Million	25,810 Added 4.52%	596,281 $122 Million
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $10.1 Million - $13 Million	53,613 Added 10.37%	570,471 $138 Million
Q3 2019 Oct 25, 2019	SELL	$174.11 - $208.62 $3.18 Million - $3.82 Million	-18,287 Reduced 3.42%	516,858 $100 Million
Q2 2019 Jul 31, 2019	BUY	$166.7 - $195.41 $89.2 Million - $105 Million	535,145 New	535,145 $0
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $83.2 Million - $93.7 Million	-459,801 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $1.24 Million - $1.45 Million	-6,941 Reduced 1.49%	459,801 $85.4 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $12.5 Million - $14.1 Million	-67,299 Reduced 12.6%	466,742 $96.8 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $2.72 Million - $3.05 Million	-16,357 Reduced 2.97%	534,041 $98.6 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $16.6 Million - $19.4 Million	-97,879 Reduced 15.1%	550,398 $93.9 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $407,796 - $455,633	-2,416 Reduced 0.37%	648,277 $113 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $109 Million - $124 Million	650,693	650,693 $121 Million

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Amgen Inc Transaction History